Analyst Upgrades

• Bunge (BG) to buy from hold at Deutsche Bank.
• Textron (TXT) to overweight from neutral at JPMorgan.
• CSX (CSX) to buy from neutral and Pulte Group (PHM) to conviction buy from neutral at Goldman.
• Aol (AOL) to buy from neutral at UBS.
• Kohlberg Capital (KCAP) to outperform from market perform at JMP Securities.
• Owens Corning (OC) to buy from neutral at BofA/Merrill.
• Jefferies (JEF) to buy from neutral at Ticonderoga.
• Harris (HRS) to outperform from perform at Oppenheimer.

Analyst Upgrades

• Netflix (NFLX) and Zions Bancorp (ZION) to outperform from neutral at Credit Suisse.
• Akamai (AKAM) to buy from neutral at Merriman.
• CSX (CSX) to overweight from equal weight at Barclays.
• Nordstrom (JWN) to buy from neutral, WellCare (WCG) to conviction buy from buy and Humana (HUM) to neutral from sell at Goldman.
• E-Commerce China Dangdang (DANG) to overweight from neutral at Piper Jaffray.
• VMware (VMW) to buy from neutral at BofA/Merrill.
• Celanese (CE) to overweight from equal weight at Morgan Stanley.

Analyst Upgrades

• Interpublic Group (IPG) to buy from hold at Deutsche Bank.
• Radware (RDWR) to outperform from perform at Oppenheimer.
• Fluor (FLR) and Waddell & Reed (WDR) to buy from hold, as well as AllianceBernstein (AB) to hold from sell, at Citigroup.
• MetroCorp (MCBI) and American Capital (AGNC) to outperform from market perform at Keefe Bruyette.
• International Flavors (IFF) to overweight from equal weight at Barclays.
• BioCryst (BCRX) and Southern Company (SO) to buy from neutral at BofA/Merrill.
• Bunge (BG) to overweight from neutral at HSBC.

"Market Vectors Agribusiness ETF (MOO) offers a great opportunity to capitalize on the move in the sector; the fund focuses on the 40 most actively traded companies in the agriculture chemical and product business," says Jim Farrish.

The exchange-traded fund specialist and editor of SectorExchange.com explains, "Below, we review the ETF as well as some individual agriculture-based stocks poised to break out on the upside.

"The agriculture stocks have been moving up aggressively since the end of June. The initial push came on the drought issues in Russia and wheat production.

"One way to capitalize on the recent fear-drenched selloff is to take advantage of attractive valuations and invest in businesses tied to the long-term agriculture story," says David Dittman.

The contributing editor to KCI's Personal Finance explains, "Rising populations and growing middle classes in emerging markets mean people will spend more on food and increase their consumption of agriculture-intensive proteins. Here are two ways to profit from increasing demand for agricultural products: Monsanto (MON) and Bunge (BG).

"These two agribusiness heavyweights -- both of which we hold in our model Growth Portfolio -- have suffered because of specific short-term issues that don't threaten their respective positions in the sector.

Bunge (BG - option chain) shares are rising today after the company announced its board has approved a stock buyback plan under which BG will repurchase up to $700 million worth of common shares through December 31, 2011. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on BG.

BG opened this morning at $49.28. So far today the stock has hit a low of $49.28 and a high of $51.90. As of 11:55, BG is trading at $51.09 up $3.33 (7.0%). The chart for BG looks neutral and S&P gives BG a neutral 3 STARS (out of 5) hold ranking.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Alcoa Inc. (NYSE: AA) kicked off the new season with a larger-than-expected loss due to the economic slump.
• Allscripts-Misys Healthcare Solutions (NASDAQ: MDRX) reported better-than-expected Q2 earnings.
• Apollo Group Inc. (NASDAQ: APOL) share price soared after its strong Q1 earnings and guidance.
• Apple Inc. (NASDAQ: AAPL) earnings prospects without CEO Steve Jobs led to an analyst's downgrade.
• Autodesk Inc. (NASDAQ: ADSK) lowered its guidance as business slows at an unprcedented rate.
• Bank of America Corp. (NYSE: BAC) reported terrible Q4 results and receivbed additional TARP money.
• Bunge Ltd. (NYSE: BG) lowered its 2008 earnings estimate due to soft soybean commodity markets.
• Citigroup Inc. (NYSE: C) posted a much bigger-than-expected loss and said it would split in two.
• Coventry Health Care Inc. (NYSE: CVH) offered full-year guidance that was less than analysts expectations.
• CSX Corp. (NYSE: CSX) forecast Q4 earnings would come in below analysts' expectations.
• CVS Caremark Corp. (NYSE: CVS) increased its quarterly dividend despite the recent lowered guidance.
• Deutsche Bank (NYSE: DB) reported a net loss for Q4 and the full year, dragging down the sector.
• Genentech Inc. (NASDAQ: DNA) revenue and earnings surged but were lower than analysts estimated.
• Intel Corp. (NASDAQ: INTC) Q4 results were in line with low expectations as the gross margin declined.
• JPMorgan Chase & Co. (NYSE: JPM) reported a huge drop in Q4 earnings but it stayed in the black.
• Lexmark International Inc. (NYSE: LXK) slashed its Q4 outlook and announced job cuts.
• Pentair Inc. (NYSE: PNR) efforts to limit an earnings decline led to a buy recommendation.
• Precision Cast Corp. (NYSE: PCP) earnings prospects following the recent rally led to an analyst's downgrade.

I made it through mid-year of tracking my 2008 picks from last December and then -- Wham! -- I went from a slight advantage to being humbled badly by the market. However difficult it is to display your failings, once again I will share all of the horrors since I posted the original story Chasing Value: Final list -- 8 stocks for 2008.

The master is still the master, Warren Buffett and his life's work Berkshire Hathaway (NYSE: BRK.B) beat me easily as well as the three indices I tracked.

For the most part, unless you started shorting stocks, there was no place to hide and most of my picks were big losers. There were two that beat Buffett and the market. The defense sector was the defensive sector it was supposed to be with Raytheon Company (NYSE: RTN) doing well on a relative scale. The other place you could have a morsel of stability was utilities and Huaneng Power International (ADR) (NYSE: HNP) lost less but not by much.

This post was writtenby Minyanville contributor Ryan Krueger.

Looks like Verasun Energy Corp. (NYSE: VSE), a formerly popular ethanol stock and second largest producer, has won court permission to cancel contracts signed to purchase corn. It is now in bankruptcy. I'm also hearing about a lot of excess ethanol funded by your tax dollars being sold to other countries. That worked out well.

The mistaken policy and debates are endless, the trades are what I am chewing on instead. I think consumers of corn at lower prices are set up for some awfully tasty '09 comparisons for their bottom lines. Corn Products International, Inc. (NYSE: CPO), after Bunge Limited (NYSE: BG) backed away from its take-over, is a name I have re-entered from the long side after closing out my position just after the non-merger was announced and shares traded twice what they are now. They sweeten something you'll eat or drink in the next hour.

Longer term, however, I am even more interested in the ingredients, not the end products. But it's still early. I have been long gone from 2008 corn contracts for quite some time, but am starting to poke around out on the futures curve. On the same day this court ruling was announced abolishing artificial demand, quiet real demand emerged as Mexico was a big buyer of corn.

I'll take a few billion eaters over several million drivers any day.

In the agricultural sector, it's been nirvana for investors. But are prices too high?

Perhaps not. Take Bunge Ltd. (NYSE: BG), which is a major fertilizer and oilseed producer. Bunge has agreed to pay $4.4 billion for Corn Products International Inc. (NYSE: CPO), a producer of finished corn products. Some of its customers include biggies like Coca-Cola (NYSE: KO). This is a stock-for-stock deal. In other words, why not take advantage of the high market caps?

Both companies have rich histories. Corn Products got its start in 1906 and Bunge was founded in 1818. But it's the future that matters, and Bunge is certainly bullish on the global growth trends in the agricultural markets. To take advantage of this, it makes sense to bulk up. Corn Products will expand Bunge's offerings as well as provide some diversification.

In fact, Bunge also raised its full-year 2008 earnings forecast from $7.10-$7.40 to $9.35-$9.65. This doesn't even include the impact of the Corn Products transaction.

Tom Taulli is the author of various books, including The Complete M&A Handbook and The Edgar Online Guide to Decoding Financial Statements. He also operates MergerBook.com.

After five months of tracking my 2008 picks, it is rewarding to finally have a breakthrough -- topping the three major stock indices and Berkshire Hathaway (NYSE: BRK.B) too. It has been painful to have to report each month that I was being bested. However, since I have not seen anything contradicting my original rationale for my eight picks I stood my ground.

This past month saw great improvement. For the first time since I posted the original story Chasing Value: Final list -- 8 stocks for 2008, five of the eight stocks are up:

Moving into positive territory by pennies was Loews Corporation (NYSE: LTR). Among its holdings is a 51% stake in Diamond Offshore Drilling, Inc. (NYSE: DO) that has been doing well as the world remains desperate for more oil and natural gas.

Bunge Limited (NYSE: BG) was the other stock to cross the line into the black, while Valero Energy Corp. (NYSE: VLO), although improving, remains my worst performer. It is still down almost 28% after five months.

The gap between the Dow Jones Industrial Average, Standard & Poor's 500 Index and the technology heavy NASDAQ Composite Index narrowed substantially so that the three are tracking each other very closely. Stocks like Apple, Inc (NASDAQ: AAPL) and Google Inc. (NASDAQ: GOOG) continue to gain significantly and their outlooks have not been shaken amid overall pessimistic economic forecasts.

TheStreet.com's Jim Cramer says the bull story here has more causes than just a weak greenback.

Better seeds and more fertilizer. That's it. Those are the technology weapons in the war against food shortages caused in the short term by a worldwide obsession with biofuels (we are the worst offender, of course) and in the long term by the increased affluence in China and India, which leads to more nutritious, protein-filled diets.

Both forces, when combined with worldwide droughts and failed harvests, not augmented by the U.S. -- we are late to start with our corn season -- are driving prices up to ridiculous levels. I have no doubt that if tomorrow the president of the United States said he was suspending the biofuel mandates for ethanol that we would see a collapse in food pricing. But I also have no doubt that this inept administration could never figure that out.

So, the solution comes to all of the stocks that were crushed yesterday: Monsanto (NYSE: MON) (Cramer's Take), Potash (NYSE: POT) (Cramer's Take), Mosaic (NYSE: MOS) (Cramer's Take) and Agrium (NYSE: AGU) (Cramer's Take). Without better seeds that produce higher yields, without more fertilizer that increases yields, we are going to be facing a long-term continuation of these price increases and the attendant inflation and food riots. Inflation, by the way, that has nothing to do with the Fed, unless the Fed is also a big granary hoarding wheat and corn.

Bunge Limited (NYSE: BG) is an integrated agribusiness, fertilizer and food products concern. The company is a leading global processor of soybeans and other grains, a leading provider of products and services to the South American farming community and a major U.S. food processor. Some of Bunge's agribusiness products are used for industrial purposes, including renewable fuels like biodiesel. Archer-Daniels-Midland (NYSE: ADM) is a major competitor.

Investors were pleased earlier in the month, when Bunge-DuPont (NYSE: DD) joint venture Solae Company said it would increase global prices for its soy protein ingredients by up to 30%. The firm said the increases were necessary, in order to maintain a consistent level of service, innovation and investment in research.

MOST NOTEWORTHY: The Managed Care sector, Keryx Biopharma and Citrix Systems were today's noteworthy downgrades:

• Goldman downgraded the Managed Care sector to Neutral from Attractive following WellPoint's (NYSE: WLP) reduced 2008 outlook. The firm said WellPoint's issues reflect a company specific underwriting error but also industry-wide pricing pressures which increase the risk of a cyclical slowdown in managed care. WellPoint was also downgraded to Neutral from Overweight at JP Morgan.
  
• Banc of America cut Keryx Biopharma (NASDAQ: KERX) to Neutral from Buy and lowered their target to $1.00 after Sulonex failed to meet its primary endpoint.
  
• Jefferies downgraded shares of Citrix Systems (NASDAQ: CTXS) to Hold from Buy, as they believe the first half of 2008 will be a tough year for software and are increasingly worried about the macro environment.

OTHER DOWNGRADES:

• Level 3 Comm (NASDAQ: LVLT) was downgraded to Underweight from Market Weight at Thomas Weisel.
  
• Texas Instruments (NYSE: TXN) was lowered to Neutral from Buy at Piper Jaffray.
  
• Credit Suisse removed Bunge Limited (NYSE: BG) from its U.S. Focus List.

Readers of this space know that the investment bias is toward large-cap companies with demonstrated business models and a competitive advantage in established markets, preferably with a favorable global trend as a support. And with the above in mind, Bunge Ltd. is worth a review.

Bunge Ltd. (NYSE: BG) is the world's No. 1 soybean processor, a leading South American fertilizer maker and provider, and a major U.S. food processor. BG is also the world's largest oilseed producer. Analysts see BG's sales advancing 13-17% in 2008, after a double-digit gain in 2007.

Further, analysts believe Bunge is well-positioned in the world's largest food production regions to take advantage of the world's fastest-growing consumption markets. In addition, analysts like BG's 80-nation footprint.

Margins may narrow slightly in 2008, due to higher commodity and energy costs. The Reuters F2008/F2009 EPS consensus estimates for BG are $6.63/$7.61.

The risks? Analysts are keeping an eye on soybean margins. A global economic slowdown would also (obviously) hurt BG's results.

The First Call mean rating for BG is: Hold [9 firms]. Mean 2008 target: $132 [high: $143, low: $120].

Stock Analysis: Bunge Ltd. is a moderate-risk stock not suitable for low-risk investors. Investors with an investment horizon longer than 2 years should be rewarded from BG's shares. Sell / Stop Loss if you were to purchase shares in this company: $72.

Disclosure: Lazzaro has no positions in stocks. In addition to private real estate holdings, he owns corporate and municipal bonds, and cash certificates of deposit.